Susquehanna Fundamental Investments’s Clovis Oncology, Inc. CLVS Stock Holding History

Susquehanna Fundamental Investments’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-115,299	Closed	-$137K	–	1589
2022 Q3	$137K	Buy	+115,299	New	+$180K	﹤0.01%	1302
2022 Q1	$519K	Sell	256,919 -43,284	-14%	-$85K	0.01%	1071
2021 Q4	$814K	Buy	300,203 +115,299	+62%	+$426K	0.02%	729
2021 Q3	$825K	Buy	+184,904	New	+$891K	0.02%	955
2021 Q2	–	Sell	-115,628	Closed	-$812K	–	1829
2021 Q1	$812K	Buy	+115,628	New	+$775K	0.01%	965
2020 Q4	–	Sell	-29,300	Closed	-$171K	–	1654
2020 Q3	$171K	Hold	29,300	–	–	0.01%	1221
2020 Q2	$198K	Buy	+29,300	New	+$222K	0.01%	840

Other funds holding CLVS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $160M AUM 21.24% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Susquehanna Fundamental Investments's CLVS Position: Q4 2022 in Review

Susquehanna Fundamental Investments sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 115,299 shares — an estimated $137K sold.

Susquehanna Fundamental Investments first reported a position in CLVS in Q2 2020 and held it in 7 quarters. The position peaked at $825K in Q3 2021. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

Susquehanna Fundamental Investments reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
Susquehanna Fundamental Investments sold 115,299 Clovis Oncology, Inc. shares in Q4 2022, an estimated $137K.
Susquehanna Fundamental Investments first reported a position in Clovis Oncology, Inc. in Q2 2020 and held it in 7 quarters.
Susquehanna Fundamental Investments's Clovis Oncology, Inc. position peaked at $825K in Q3 2021.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2022, filed 14 Feb 2023.